{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PO+ciprofloxacin", "query": { "intervention": "PO ciprofloxacin" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 15, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PO+ciprofloxacin&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-24T18:02:05.980Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03358576", "title": "Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Intra Abdominal Infections" ], "interventions": [ { "name": "Ertapenem", "type": "DRUG" }, { "name": "Sulopenem-Etzadroxil/Probenecid", "type": "DRUG" }, { "name": "Ciprofloxacin", "type": "DRUG" }, { "name": "Metronidazole", "type": "DRUG" }, { "name": "Amoxicillin-Clavulanate", "type": "DRUG" }, { "name": "Sulopenem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Iterum Therapeutics, International Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 674, "start_date": "2018-09-18", "completion_date": "2019-10-02", "has_results": true, "last_update_posted_date": "2020-12-01", "last_synced_at": "2026-09-24T18:02:05.980Z", "location_count": 12, "location_summary": "Chula Vista, California • Torrance, California • Idaho Falls, Idaho + 8 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Idaho Falls", "state": "Idaho" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Royal Oak", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03358576" }, { "nct_id": "NCT02829060", "title": "Endourology Disease Group Excellence (EDGE) Consortium: Antibiotics (Abx) for Percutaneous Nephrolithotomy (PCNL) Part 2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Nephrolithiasis", "Urinary Tract Infection (UTI)", "Sepsis" ], "interventions": [ { "name": "Nitrofurantoin 100 MG, 7d", "type": "DRUG" }, { "name": "Gentamicin, 5mg/kg", "type": "DRUG" }, { "name": "Ampicillin 2g", "type": "DRUG" }, { "name": "Nitrofurantoin 100 mg, 48 hrs", "type": "DRUG" }, { "name": "Gentamicin, 80 mg, 7d", "type": "DRUG" }, { "name": "Gentamicin, 80 mg, 48hr", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 330, "start_date": "2016-01", "completion_date": "2025-03", "has_results": false, "last_update_posted_date": "2025-03-06", "last_synced_at": "2026-09-24T18:02:05.980Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02829060" }, { "nct_id": "NCT03357614", "title": "Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Complicated Urinary Tract Infections" ], "interventions": [ { "name": "Sulopenem", "type": "DRUG" }, { "name": "Sulopenem-Etzadroxil/Probenecid", "type": "DRUG" }, { "name": "Ertapenem", "type": "DRUG" }, { "name": "Ciprofloxacin", "type": "DRUG" }, { "name": "Amoxicillin-clavulanate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Iterum Therapeutics, International Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1395, "start_date": "2018-09-18", "completion_date": "2019-12-14", "has_results": true, "last_update_posted_date": "2020-12-29", "last_synced_at": "2026-09-24T18:02:05.980Z", "location_count": 15, "location_summary": "Bellflower, California • Chula Vista, California • La Mesa, California + 11 more", "locations": [ { "city": "Bellflower", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "La Palma", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03357614" }, { "nct_id": "NCT00153634", "title": "Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cystic Fibrosis", "Chronic Bronchitis" ], "interventions": [ { "name": "IV amikacin", "type": "DRUG" }, { "name": "PO azithromycin", "type": "DRUG" }, { "name": "IV ceftazidime", "type": "DRUG" }, { "name": "PO ciprofloxacin", "type": "DRUG" }, { "name": "IV meropenem", "type": "DRUG" }, { "name": "IV piperacillin-tazobactam", "type": "DRUG" }, { "name": "IV ticarcillin-clavulanate", "type": "DRUG" }, { "name": "IV tobramycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Seattle Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "14 Years", "maximum_age": null, "sex": "ALL", "summary": "14 Years and older" }, "enrollment_count": 75, "start_date": "2004-03", "completion_date": "2007-11", "has_results": false, "last_update_posted_date": "2008-03-13", "last_synced_at": "2026-09-24T18:02:05.980Z", "location_count": 8, "location_summary": "Iowa City, Iowa • St Louis, Missouri • Cincinnati, Ohio + 4 more", "locations": [ { "city": "Iowa City", "state": "Iowa" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00153634" }, { "nct_id": "NCT03891979", "title": "Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pancreatic Cancer" ], "interventions": [ { "name": "Pembrolizumab", "type": "DRUG" }, { "name": "Ciprofloxacin 500mg PO BID days 1-29", "type": "DRUG" }, { "name": "Metronidazole 500mg PO TID days 1-29", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Months", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Months to 100 Years" }, "enrollment_count": 0, "start_date": "2019-06-25", "completion_date": "2020-06-01", "has_results": false, "last_update_posted_date": "2020-06-26", "last_synced_at": "2026-09-24T18:02:05.980Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03891979" }, { "nct_id": "NCT05286931", "title": "SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Neisseria Gonorrhoeae Infection" ], "interventions": [ { "name": "Ciprofloxacin 500 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1800, "start_date": "2022-03-03", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2022-03-18", "last_synced_at": "2026-09-24T18:02:05.980Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT05286931" }, { "nct_id": "NCT00002850", "title": "Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Infection", "Multiple Myeloma" ], "interventions": [ { "name": "ciprofloxacin", "type": "DRUG" }, { "name": "ofloxacin", "type": "DRUG" }, { "name": "160 mg trimethoprim and 800 mg sulfamethoxazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gary Morrow", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 212, "start_date": "1997-03", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2015-11-11", "last_synced_at": "2026-09-24T18:02:05.980Z", "location_count": 43, "location_summary": "Mobile, Alabama • Cedar Rapids, Iowa • Ottumwa, Iowa + 32 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Cedar Rapids", "state": "Iowa" }, { "city": "Ottumwa", "state": "Iowa" }, { "city": "Sioux City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002850" }, { "nct_id": "NCT05462496", "title": "Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pancreatic Cancer" ], "interventions": [ { "name": "Biopsy", "type": "PROCEDURE" }, { "name": "FOLFIRINOX", "type": "DRUG" }, { "name": "Ciprofloxacin", "type": "DRUG" }, { "name": "Metronidazole", "type": "DRUG" }, { "name": "Pembrolizumab", "type": "DRUG" }, { "name": "Surgical Resection", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 25, "start_date": "2023-03-16", "completion_date": "2028-04", "has_results": false, "last_update_posted_date": "2024-10-15", "last_synced_at": "2026-09-24T18:02:05.980Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05462496" }, { "nct_id": "NCT04678154", "title": "Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Post Operative Surgical Site Infection" ], "interventions": [ { "name": "Standard of care", "type": "DRUG" }, { "name": "Vancomycin and Tobramycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Major Extremity Trauma Research Consortium", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 600, "start_date": "2021-05-07", "completion_date": "2029-03-31", "has_results": false, "last_update_posted_date": "2026-07-22", "last_synced_at": "2026-09-24T18:02:05.980Z", "location_count": 31, "location_summary": "Redwood City, California • San Francisco, California • Aurora, Colorado + 25 more", "locations": [ { "city": "Redwood City", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "West Palm Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04678154" }, { "nct_id": "NCT02252978", "title": "Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "ciprofloxacin", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" }, { "name": "quality-of-life assessment", "type": "OTHER" }, { "name": "laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 0, "start_date": "2016-07", "completion_date": "2016-07", "has_results": false, "last_update_posted_date": "2018-07-05", "last_synced_at": "2026-09-24T18:02:05.980Z", "location_count": 2, "location_summary": "Salisbury, North Carolina • Winston-Salem, North Carolina", "locations": [ { "city": "Salisbury", "state": "North Carolina" }, { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02252978" } ] }